Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is a 50% increase over the number of companies inspected in the previous quarter, when four companies received four inspections.
Most of the companies inspected at the time were involved in the Biologics, Food and Cosmetics, and Drugs sectors. The second most common type of company inspected worked in the Veterinary sector.
There were four companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Two should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Blue Line Food Service Distribution | Food and Cosmetics | 12/06/2024 | Voluntary Action Indicated (VAI) |
Future Pak | Drugs | 10/23/2024 | No Action Indicated (NAI) |
Future Pak, Ltd. | Drugs | 10/15/2024 | Voluntary Action Indicated (VAI) |
Future Pak, Ltd. | Veterinary | 10/15/2024 | Voluntary Action Indicated (VAI) |
Gerrit J. Verburg Company | Food and Cosmetics | 11/26/2024 | No Action Indicated (NAI) |
Henry Ford Providence Southfield | Biologics | 10/10/2024 | No Action Indicated (NAI) |
The American National Red Cross | Biologics | 10/03/2024 | No Action Indicated (NAI) |